ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Decline in Short Interest

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 11,800 shares, a decrease of 71.8% from the December 31st total of 41,800 shares. Based on an average trading volume of 12,100 […]

Leave a Reply

Your email address will not be published.

Previous post BioCardia, Inc. (NASDAQ:BCDA) Short Interest Down 39.6% in January
Next post ‘Flower’ in full bloom as Wild blank Canadiens